Latest

chemotherapy

·January 22, 2018·5 min read

Combination Chemotherapy May Significantly Improve Treatment for Glioblastoma

Researchers report the addition of an FDA approved chemotherapy drug called hydroxyyurea to temozolomide helps to increase survival rates in animal models of glioblastoma.

Brain Cancer Featured Neurology Psychology

·December 14, 2017·4 min read

Inflammation Linked to Chemo Brain

A new study reports inflammation in the blood may play a role in cognitive problems following chemotherapy. Researchers report identifying the inflammatory biomarkers and reducing inflammation may prevent some of the symptoms of chemo brain.

Featured Neurology

·November 29, 2017·6 min read

Synthetic Cannabis-Like Drug Reduces Sleep Apnea

Dronabinol, a drug that contains a synthetic version of the molecule tetrahydrocannabinol, appears to be both safe and effective in treating obstructive sleep apnea, a new study reports.

Brain Cancer Featured Neurology

·November 27, 2017·7 min read

Cancer Drug Starts Clinical Trials in Human Brain Cancer Patients

A new drug has been cleared for human trials in patients with anaplastic astrocytoma and glioblastoma brain cancers. The drug, PAC-1, is reported to spur cancer cells to self destruct and has proven to be effective in animal models of brain cancers.

Brain Cancer Featured Neuroscience Psychology

·September 19, 2017·5 min read

Increased Physical Activity in Breast Cancer Survivors Boosts Cognition

Many breast cancer survivors report cognitive problems following treatment. New research from UCSD finds breast cancer survivors who increase physical activity and embark on regular exercise experience improved mental processing.

Brain Cancer Featured Neurology

·May 1, 2017·6 min read

Super Computer Assists in Search For Better Cancer Treatments

Researchers are turning to supercomputers in the quest to discover new treatments and targets for cancers.

Brain Cancer Featured Neurology Open Neuroscience Articles Psychology

·April 25, 2017·5 min read

Chemo Drug May Increase Vulnerability to Depression

Temozolomide, a chemotherapy drug used to treat brain cancer, could increase risks of developing depression by preventing neurogenesis, a new study reports.

Image shows a brain scan from a glioblastoma patient.

Brain Cancer Featured Neurology Open Neuroscience Articles

·April 14, 2017·6 min read

Immunotherapy for Glioblastoma Well Tolerated and Increases Survival

Glioblastmoa brain cancer patients who received an experimental vaccines in combination with chemotherapy showed improved suitability and tolerated the treatment well, a new study reports.

Brain Cancer Featured Neuroscience Psychology

·April 12, 2017·5 min read

Potential Therapy to Prevent Chemobrain in Cancer Patients

A new compound prevents cognitive decline associated with chemotherapy treatments in rats, a new study reports.

Featured Genetics Neurology Open Neuroscience Articles

·February 20, 2017·8 min read

Multiple Sclerosis Treatment That Resets Immune System May Halt Disease for Five Years

A new treatment for multiple sclerosis prevents symptoms of the disease from worsening for up to five years in 46% of patients treated, a new study reports.